[HTML][HTML] Role of epigenetics in biology and human diseases

A Moosavi, AM Ardekani - Iranian biomedical journal, 2016 - ncbi.nlm.nih.gov
For a long time, scientists have tried to describe disorders just by genetic or environmental
factors. However, the role of epigenetics in human diseases has been considered from a …

E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions

SM Hosseini, I Okoye, MG Chaleshtari… - Clinica Chimica …, 2019 - Elsevier
Despite the medical advances of the 21st century, the incidence of cancer continues to
increase and the search for a universal cure remains a major health challenge. Our lack of …

Epigenetic biomarkers in colorectal cancer: premises and prospects

M Zamani, SV Hosseini, P Mokarram - Biomarkers, 2018 - Taylor & Francis
Context: Colorectal cancer is one of the most common cancers worldwide. Epigenetic
alterations play an important role in the pathogenesis of the colorectal cancer. Objective …

The effects of dietary polyunsaturated fatty acids on miR-126 promoter DNA methylation status and VEGF protein expression in the colorectal cancer cells

M Moradi Sarabi, SA Zahedi, N Pajouhi, P Khosravi… - Genes & nutrition, 2018 - Springer
Background There is increasing evidence indicating an aberrant expression of miRNAs in
colorectal cancer (CRC) development. Growing evidence has suggested that …

Ubiquitin‑conjugating enzymes as potential biomarkers and therapeutic targets for digestive system cancers

X Lei, X Hu, Q Lu, W Fu, W Sun, Q Ma… - Oncology …, 2023 - spandidos-publications.com
Digestive system cancers are the leading cause of cancer-related death worldwide due to
their high morbidity and mortality rates. The current treatment methods include surgical …

[HTML][HTML] Polyunsaturated fatty acids and DNA methylation in colorectal cancer

MM Sarabi, RM Khorramabadi, Z Zare… - World journal of clinical …, 2019 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) has been designated a major global problem, especially due to its
high prevalence in developed countries. CRC mostly occurs sporadically (75%-80%), and …

Epigenetic alteration in colorectal cancer: a biomarker for diagnostic and therapeutic application

HYS Essa, G Kusaf, O Yuruker… - Global Medical …, 2022 - thieme-connect.com
Colorectal cancer (CRC) is the leading cause of cancer death worldwide. A crucial process
that initiates and progresses CRC is various epigenetic and genetic changes occurring in …

Hypomethylated ubiquitin-conjugating enzyme2 Q1 (UBE2Q1) gene promoter in the serum is a promising biomarker for hepatitis B virus-associated hepatocellular …

N Hu, XP Fan, YC Fan, LY Chen, CY Qiao… - The Tohoku Journal of …, 2017 - jstage.jst.go.jp
Aberrant DNA methylation, which can be detected in circulating cell-free DNA (cfDNA), is
one of the major epigenetic alterations in hepatocellular carcinoma (HCC). UBE2Q1, a …

Genetic and molecular origins of colorectal Cancer among the Iranians: an update

MR Abbaszadegan, M Moghbeli - Diagnostic pathology, 2018 - Springer
Background Colorectal cancer (CRC) is one the leading causes of cancer related deaths
among Iranians. Despite the various progresses in new therapeutic methods, it has still a …

DNA Methylation Profiles of PSMA6, PSMB5, KEAP1, and HIF1A Genes in Patients with Type 1 Diabetes and Diabetic Retinopathy

Z Svikle, N Paramonova, E Siliņš, L Pahirko, L Zariņa… - Biomedicines, 2024 - mdpi.com
We explored differences in the DNA methylation statuses of PSMA6, PSMB5, HIF1A, and
KEAP1 gene promoter regions in patients with type 1 diabetes and different diabetic …